Non-steroidal anti-inflammatory drugs and cardiovascular risk : a rheumatologist's reply

Whitelaw, David (2007-12)


The original publication is available at


To the Editor: The cyclo-oxygenase-2 (COX-2) inhibitors and other non-steroidal anti-inflammatory drugs (NSAIDs) have been the subject of scrutiny generated mainly by evidence suggesting that rofecoxib is associated with increased cardiovascular risk. Chin and Commerford1 have summarised some of the large volume of data; however, a critical review of published work yields interesting insights.

Please refer to this item in SUNScholar by using the following persistent URL:
This item appears in the following collections: